Finnish VTT spin-out Onego Bio Ltd raises €10m

The cellular agriculture spin-off Onego Bio Ltd has been seeded with €10m to use its Trichoderma platform to establish an animal-free egg protein production.

Read more

Moderna wants to extent its European footprint

The former mRNA start-up Moderna Inc is set to expand its commercial network in six European nations to become a gobally active vaccine company.

Read more

Centauri Therapeutics starting with £24m financing

Antimicrobial resistance specialist Centauri Therapeutics Ltd has closed a £24m Series A round to identify novel therapeutic candidates using the Alphamer technology.

Read more

Curve Therapeutics in US$1.7bn deal with MSD

Curve Therapeutics has inked a contract with US pharma giant Merck & Co. (MSD) to screen novel small molecule drug candidates against five MSD targets.

Read more

Newton Biocapital launches new NBC III fund

Newton Biocapital has launched a new life sciences fund with initial capital commitments of €50m and a target size of €150m.

Read more

New funds to boost European life sciences

European investment firm LSP has closed its European life sciences fund LSP at €1 bn. Additionally, a €10bn fund of funds was greenlighted at the EU Council in Paris.

Read more

BioNTech collaborates with AGC Biologics

AGC Biologics supports BioNTech’s manufacturing of an Omicron-based vaccine with plasmids for in vitro transcription.

Read more

EU Council confirms European Scale-up Initiative

EU Members States agreed on Tuesday to launch the pan-European Scale-up Initiative, which is aimed to provide €10bn for late-state tech companies.

Read more